Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pediatric Endocrinology · Congenital Adrenal Hyperplasia

Are False Positive CAH Newborn Screens Common for Babies?

At a Glance

False-positive newborn screens for classic CAH are common because prematurity, low birth weight, illness, early testing, and screening methods can raise 17-OHP. A positive screen is not a diagnosis, but follow-up testing is needed because untreated CAH can cause dangerous salt and fluid loss.

Yes, false positive newborn screens for classic Congenital Adrenal Hyperplasia (CAH) are very common. While receiving a positive result can be incredibly frightening for parents, it is important to know that a screening test is a signal, not a diagnosis. The initial test simply flags babies who need further evaluation. Depending on the screening program’s methods, many—or even most—positive results turn out to be false positives [1][2].

However, because the test can also indicate a serious condition, every positive screen must be evaluated immediately.

Why Do False Positives Happen?

The standard newborn screen checks for classic CAH by measuring a hormone called 17-hydroxyprogesterone (17-OHP). This hormone builds up in the blood when the body lacks the enzyme needed to make cortisol. However, several normal or temporary factors can cause a healthy baby’s 17-OHP levels to be high:

  • Prematurity and Low Birth Weight: Babies born early or small naturally have higher 17-OHP levels as part of their normal development [3][4].
  • Physical Stress or Illness: Physical stress during a difficult delivery, birth asphyxia, or other neonatal illnesses can cause a temporary spike in 17-OHP [5][6].
  • Testing Methods: The first-round test used by most states, called an immunoassay, sometimes cross-reacts with other harmless fetal hormones, mistakenly reading them as 17-OHP [7][8].
  • Timing of the Test: A newborn’s 17-OHP levels are naturally high around the time of birth. If the heel-prick blood spot is collected early, it is more likely to trigger a positive result [9][10].

What Happens Next?

Even though false positives are common, doctors take every positive screen seriously. Untreated classic CAH can cause a salt-wasting crisis—a rapid loss of sodium and water that leads to dangerous dehydration and low blood pressure [9][11]. Because an infant may appear well before a crisis begins, a positive screen must always be followed up promptly [11].

To find out for sure whether your baby has CAH or if the screen was a false positive, your medical team will run confirmatory tests. Depending on your baby’s specific screening numbers, this evaluation may involve:

  • A more precise second-step blood spot test (often called LC-MS/MS steroid profiling) that accurately separates 17-OHP from other normal fetal hormones [7][8].
  • Urgent serum bloodwork drawn from a vein. This often includes testing 17-OHP, cortisol, and electrolytes (sodium and potassium) to see exactly how your baby’s adrenal glands are functioning right now [12][9]. Genetic testing is sometimes used later to help clarify the diagnosis, but it does not replace these immediate blood tests [13].

Follow your doctor’s explicit plan for testing and evaluation. Do not simply wait and monitor at home unless specifically instructed to do so by a pediatric specialist. Completing the follow-up testing promptly helps ensure timely diagnosis and treatment.

When to Seek Urgent Help

If you are waiting for follow-up appointments or confirmatory test results, you must monitor your baby closely. Go to the nearest emergency room immediately and tell them your baby had a positive newborn screen for CAH if you notice any of the following signs of a salt-wasting crisis:

  • Repeated vomiting or an inability to keep feeds down
  • Unusual sleepiness, lethargy, or unresponsiveness
  • Limpness, weakness, or a seizure
  • Signs of dehydration, such as significantly fewer wet diapers than normal

Common questions in this guide

How often is a positive CAH newborn screen a false alarm?
False-positive results for classic CAH are common, and many positive screens do not mean that a baby has the condition. The result is only a screening signal, so every positive screen still needs prompt follow-up to rule out true CAH.
What can make a healthy newborn's CAH screen come back positive?
The screen measures 17-hydroxyprogesterone, or 17-OHP, which is naturally higher around birth and can be elevated in premature or low-birth-weight babies. Illness or stress during delivery, collecting the sample very early, and cross-reactions in the first test can also cause a false positive.
What tests confirm or rule out CAH after a positive screen?
The medical team may repeat the test with a more specific LC-MS/MS steroid profile and obtain blood from a vein to measure 17-OHP, cortisol, sodium, and potassium. Genetic testing may be added later, but it does not replace urgent blood tests when immediate evaluation is needed.
What should I do if my baby has symptoms while waiting for CAH follow-up?
Go to the nearest emergency room immediately and say that your baby had a positive newborn screen for CAH if the baby has repeated vomiting, cannot keep feeds down, is unusually sleepy or unresponsive, is limp or weak, has a seizure, or has far fewer wet diapers. These can signal a salt-wasting crisis, which requires urgent care.
Does a positive newborn screen prove that my baby has classic CAH?
No. Newborn screening identifies babies who need further evaluation, but it cannot by itself diagnose CAH; confirmatory blood or steroid-profile testing is needed.

Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.

    Kopacek C, de Castro SM, Prado MJ, et al.

    BMC pediatrics 2017; (17(1)):22 doi:10.1186/s12887-016-0772-x.

    PMID: 28095810
  2. 2

    Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand.

    de Hora MR, Heather NL, Webster DR, et al.

    International journal of neonatal screening 2022; (8(4)) doi:10.3390/ijns8040056.

    PMID: 36278626
  3. 3

    Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns.

    Yoon YA, Woo S, Kim MS, et al.

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2023; (131(4)):216-221 doi:10.1055/a-2022-8399.

    PMID: 36854385
  4. 4

    17-hydroxiprogesterone values in healthy preterm infants.

    Mendoza-Rojas VC, Díaz-Martínez LA, Mantilla-Mora G, et al.

    Colombia medica (Cali, Colombia) 2017; (48(4)):161-166 doi:10.25100/cm.v43i4.2983.

    PMID: 29662257
  5. 5

    Evaluation of factors associated with elevated newborn 17-hydroxyprogesterone levels.

    Anandi VS, Shaila B

    Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(6)):677-681.

    PMID: 28489558
  6. 6

    [UMBILICAL CORD CORTISOL LEVELS DO NOT CORRELATE WITH 17-HYDROXYPROGESTERONE LEVELS IN THE NEWBORN SCREENING TEST].

    Weissmann R, Miller N, Litmanovitz I, Arnon S

    Harefuah 2020; (159(10)):726-730.

    PMID: 33103390
  7. 7

    Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.

    Morejón García G, García de la Rosa I, González Reyes EC, et al.

    Clinica chimica acta; international journal of clinical chemistry 2018; (485()):311-315 doi:10.1016/j.cca.2018.07.019.

    PMID: 30006291
  8. 8

    Liquid chromatography-tandem mass spectrometry analysis of 17-hydroxyprogesterone in dried blood spots revealed matrix effect on immunoassay.

    Han L, Tavakoli NP, Morrissey M, et al.

    Analytical and bioanalytical chemistry 2019; (411(2)):395-402 doi:10.1007/s00216-018-1449-0.

    PMID: 30456606
  9. 9

    Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.

    Miller WL

    Hormone research in paediatrics 2019; (91(6)):416-420 doi:10.1159/000501396.

    PMID: 31450227
  10. 10

    The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.

    Jiang X, Tang F, Feng Y, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(11)):1253-1258.

    PMID: 31603856
  11. 11

    Moderate congenital adrenal hyperplasia in two girls diagnosed by newborn screening.

    Banaszak-Ziemska M, Małecka E, Łacna K, et al.

    Pediatric endocrinology, diabetes, and metabolism 2021; (27(4)):291-297 doi:10.5114/pedm.2021.109123.

    PMID: 35114771
  12. 12

    Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme.

    Lai F, Srinivasan S, Wiley V

    International journal of neonatal screening 2020; (6(3)):63 doi:10.3390/ijns6030063.

    PMID: 33117905
  13. 13

    Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

    Choi JH, Kim GH, Yoo HW

    Annals of pediatric endocrinology & metabolism 2016; (21(1)):1-6 doi:10.6065/apem.2016.21.1.1.

    PMID: 27104172

This information about a positive CAH newborn screen is for education only and is not medical advice. Follow your newborn screening team's instructions promptly, and seek emergency care if your baby develops concerning symptoms.